These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 8015765)

  • 1. Molecular biology and genetics of epithelial ovarian cancer.
    Baker VV
    Obstet Gynecol Clin North Am; 1994 Mar; 21(1):25-40. PubMed ID: 8015765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival in familial, BRCA1-associated, and BRCA2-associated epithelial ovarian cancer. United Kingdom Coordinating Committee for Cancer Research (UKCCCR) Familial Ovarian Cancer Study Group.
    Pharoah PD; Easton DF; Stockton DL; Gayther S; Ponder BA
    Cancer Res; 1999 Feb; 59(4):868-71. PubMed ID: 10029077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The biology of ovarian cancer.
    Auersperg N; Edelson MI; Mok SC; Johnson SW; Hamilton TC
    Semin Oncol; 1998 Jun; 25(3):281-304. PubMed ID: 9633841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BRCA-1 in sporadic epithelial ovarian cancer: lessons learned from the genetics of hereditary disease.
    Cannistra SA
    Clin Cancer Res; 2007 Dec; 13(24):7225-7. PubMed ID: 18094398
    [No Abstract]   [Full Text] [Related]  

  • 5. OPCML at 11q25 is epigenetically inactivated and has tumor-suppressor function in epithelial ovarian cancer.
    Sellar GC; Watt KP; Rabiasz GJ; Stronach EA; Li L; Miller EP; Massie CE; Miller J; Contreras-Moreira B; Scott D; Brown I; Williams AR; Bates PA; Smyth JF; Gabra H
    Nat Genet; 2003 Jul; 34(3):337-43. PubMed ID: 12819783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Familial ovarian cancer.
    Ngan HY; Shepherd JH
    Br J Hosp Med; 1994 Jul 13-Aug 16; 52(2-3):99-102. PubMed ID: 7952791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncogenes in gynecologic malignancy.
    Baker V
    Curr Opin Obstet Gynecol; 1992 Feb; 4(1):75-80. PubMed ID: 1543833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BRCA1/2 mutation status influences somatic genetic progression in inherited and sporadic epithelial ovarian cancer cases.
    Ramus SJ; Pharoah PD; Harrington P; Pye C; Werness B; Bobrow L; Ayhan A; Wells D; Fishman A; Gore M; DiCioccio RA; Piver MS; Whittemore AS; Ponder BA; Gayther SA
    Cancer Res; 2003 Jan; 63(2):417-23. PubMed ID: 12543797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene expression and prognostic significance in ovarian cancer.
    Tammela J; Odunsi K
    Minerva Ginecol; 2004 Dec; 56(6):495-502. PubMed ID: 15729202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RAD52 Y415X truncation polymorphism and epithelial ovarian cancer risk in Australian women.
    Kelemen L; Spurdle AB; Purdie DM; Gertig D; Chenevix-Trench G
    Cancer Lett; 2005 Feb; 218(2):191-7. PubMed ID: 15670896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in the management of epithelial ovarian cancer.
    Berkenblit A; Cannistra SA
    J Reprod Med; 2005 Jun; 50(6):426-38. PubMed ID: 16050567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microarray expression identification of differentially expressed genes in serous epithelial ovarian cancer compared with bulk normal ovarian tissue and ovarian surface scrapings.
    Grisaru D; Hauspy J; Prasad M; Albert M; Murphy KJ; Covens A; Macgregor PF; Rosen B
    Oncol Rep; 2007 Dec; 18(6):1347-56. PubMed ID: 17982616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic alterations related to lymph node metastasis and peritoneal dissemination in epithelial ovarian cancers.
    Umayahara K; Numa F; Inokuma A; Sueoka K; Kawasaki K; Hirakawa H; Emoto T; Sakaguchi Y; Nawata S; Ogata H; Sakamoto M; Hasumi K; Kawauchi S; Sasaki K; Kato H
    Oncol Rep; 2002; 9(5):1115-9. PubMed ID: 12168082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of p53 mutation and p53 overexpression in advanced epithelial ovarian cancer: a Gynecologic Oncology Group Study.
    Havrilesky L; Darcy kM; Hamdan H; Priore RL; Leon J; Bell J; Berchuck A;
    J Clin Oncol; 2003 Oct; 21(20):3814-25. PubMed ID: 14551300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The biology of ovarian cancer of epithelial origin.
    Rabinerson D; Kaplan B; Levavi H; Neri A
    Isr J Med Sci; 1996 Nov; 32(11):1128-33. PubMed ID: 8960089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p53 mutations in epithelial ovarian cancers: possible role in predicting chemoresistance.
    Laframboise S; Chapman W; McLaughlin J; Andrulis IL
    Cancer J; 2000; 6(5):302-8. PubMed ID: 11079169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patterns of gene expression in different histotypes of epithelial ovarian cancer correlate with those in normal fallopian tube, endometrium, and colon.
    Marquez RT; Baggerly KA; Patterson AP; Liu J; Broaddus R; Frumovitz M; Atkinson EN; Smith DI; Hartmann L; Fishman D; Berchuck A; Whitaker R; Gershenson DM; Mills GB; Bast RC; Lu KH
    Clin Cancer Res; 2005 Sep; 11(17):6116-26. PubMed ID: 16144910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short androgen receptor allele length is a poor prognostic factor in epithelial ovarian carcinoma.
    Li AJ; Baldwin RL; Karlan BY
    Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3667-73. PubMed ID: 14506156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biomarker discovery in epithelial ovarian cancer by genomic approaches.
    Mok SC; Elias KM; Wong KK; Ho K; Bonome T; Birrer MJ
    Adv Cancer Res; 2007; 96():1-22. PubMed ID: 17161674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tubal and ovarian pathways to pelvic epithelial cancer: a pathological perspective.
    Piek JM; Verheijen RH; van Diest PJ
    Histopathology; 2009 Mar; 54(4):494-5. PubMed ID: 19309405
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.